COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
16/07/2026
Second-Quarter and First-Half 2026 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
La Croix-Rouge canadienne vient en aide aux communautés frappées par les inondations à Ottawa
16/07/2026
Les sommes amassées soutiendront le rétablissement des personnes touchées par les inondations. OTTAWA, Ontario, 16 juill. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne travaille étroitement avec la Ville d’Ottawa [...]
Trethera and UCLA Publish Comprehensive Review Highlighting Deoxycytidine Kinase as a Novel Metabolic Target for Cancer Therapy
16/07/2026
Peer-reviewed publication positions TRE-515 as the first clinically tested dCK inhibitor and outlines a new therapeutic framework for targeting nucleotide metabolism in tumors LOS ANGELES, July 16, 2026 (GLOBE NEWSWIRE [...]
Canadian Red Cross supports communities impacted by Ottawa flooding
16/07/2026
Funds raised will help people affected by the floods with their recovery OTTAWA, Ontario, July 16, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working closely with the City of Ottawa and community partners to [...]
NativePath 2026: Launch Effective Native Path Creatine Supplements for Seniors To Support Muscle Building and Strength with L-Leucine in USA
16/07/2026
Announcing NativePath Creatine Supplement combines creatine monohydrate, L-leucine, and L-carnitine to support muscle strength, recovery, energy, and lean muscle growth for an active lifestyle and daily wellness routine [...]
Society for Medical Decision Making Honors UMIT TIROL and Harvard Professor Uwe Siebert with 2026 Career Achievement Award
16/07/2026
OSLO, Norway, July 16, 2026 (GLOBE NEWSWIRE) -- The Society for Medical Decision Making (SMDM) presented its highest career honor, the 2026 Career Achievement Award , to Professor Uwe Siebert, MPH, MSc, ScD , of UMIT [...]
EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
16/07/2026
Second-Quarter and First-Half 2026 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV400, the Industry’s First Known CD22-Directed In Vivo CAR T Cell Therapy for Relapsed/Refractory B Cell Malignancies
16/07/2026
The company’s lead internal program expands its in vivo CAR T clinical pipeline for patients with relapsed/refractory B cell malignancies First patient expected to be dosed in Q3 2026 SEATTLE, July 16, 2026 (GLOBE [...]
Sonus Microsystems’ Autonomous Ultrasound AI Platform Selected for Major ARPA-H Maternal Health Award
16/07/2026
Sonus’s ultrasound AI platform will power a point-of-care test that enables frontline clinicians to better assess placental health and flag pregnancies at risk of fetal hypoxia. VANCOUVER, British Columbia, July 16, [...]
New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
16/07/2026
ROCKAWAY, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation technologies, today [...]
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
16/07/2026
Following the XcellaraHeart™ announcement, the Company outlines its broader development model, pairing a clinically studied mobilization base with a planned series of targeted signaling formulas LAS VEGAS, July 16, 2026 [...]
TerrAscend to Host Second Quarter 2026 Earnings Conference Call
16/07/2026
TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (the “Company”) (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis operator, today announced that it will host a scheduled conference call to [...]
Marius Pharmaceuticals Welcomes Department of Defense's New Testosterone Screening Initiative for U.S. Service Members
16/07/2026
RALEIGH, N.C., July 16, 2026 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. , a specialty pharmaceutical company advancing the science of testosterone therapy and hormone health, today welcomed Defense Secretary Pete [...]
Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
16/07/2026
Vancouver, Canada, July 16, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering non‑hallucinogenic neuroplastogen‑derived treatments for Alcohol Use [...]
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
16/07/2026
New initiative builds on EN3ZYME™ launch and highlights scalability of the Dapibus™ platform JUPITER, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a [...]
RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology
16/07/2026
Round includes participation from Medtronic and top healthcare investors MIAMI, July 16, 2026 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a medical technology company developing next-generation aspiration technology for the [...]
Better Blend to open two new Cincinnati-area locations
16/07/2026
New Hyde Park and Kenwood locations strengthen Greater Cincinnati presence CINCINNATI, July 16, 2026 (GLOBE NEWSWIRE) -- Better Blend, the Northern Kentucky-founded smoothie and wellness brand, is continuing its rapid [...]
Arcutis Expands Board of Directors with Appointment of Chris Peetz
16/07/2026
WESTLAKE VILLAGE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in immuno-dermatology, [...]
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
16/07/2026
One trial, SIGMA, will evaluate Grifols’ intravenous immunoglobulin (Ig) GAMUNEX ® -C (immune globulin injection [human], 10% caprylate chromatography purified) plus standard medical treatment in patients with secondary [...]

Pages